132 related articles for article (PubMed ID: 35802949)
21. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
[TBL] [Abstract][Full Text] [Related]
22. Oligo-based aCGH analysis reveals cryptic unbalanced der(6)t(X;6) in pediatric t(12;21)-positive acute lymphoblastic leukemia.
Kjeldsen E
Exp Mol Pathol; 2016 Aug; 101(1):38-43. PubMed ID: 27215399
[TBL] [Abstract][Full Text] [Related]
23. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
24. RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
Gaidzik VI; Bullinger L; Schlenk RF; Zimmermann AS; Röck J; Paschka P; Corbacioglu A; Krauter J; Schlegelberger B; Ganser A; Späth D; Kündgen A; Schmidt-Wolf IG; Götze K; Nachbaur D; Pfreundschuh M; Horst HA; Döhner H; Döhner K
J Clin Oncol; 2011 Apr; 29(10):1364-72. PubMed ID: 21343560
[TBL] [Abstract][Full Text] [Related]
25. [Clinical Characteristics of Acute Myeloid Leukemia Patients with RUNX1 Gene Mutation].
Ni ZF; Ma LJ; Shi LL; Shen PL; Zhao JQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1411-1416. PubMed ID: 34627418
[TBL] [Abstract][Full Text] [Related]
26. Trisomy 8 in acute myeloid leukemia.
Hemsing AL; Hovland R; Tsykunova G; Reikvam H
Expert Rev Hematol; 2019 Nov; 12(11):947-958. PubMed ID: 31422708
[No Abstract] [Full Text] [Related]
27. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?
Foley N; Van Ziffle J; Yu J; Qi Z; Grenert JP; Yeh I; Bastian B; Kogan S; Mannis GN
Cancer Genet; 2017 Oct; 216-217():74-78. PubMed ID: 29025598
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
[TBL] [Abstract][Full Text] [Related]
29. Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome.
Kameoka J; Funato T; Obara Y; Kadowaki I; Yokoyama H; Kimura T; Tomiya Y; Yamada M; Ishikawa I; Takagawa M; Sasaki O; Kimura J; Harigae H; Miura I; Meguro K; Kaku M; Sasaki T
Cancer Genet Cytogenet; 2001 Jan; 124(2):159-64. PubMed ID: 11172910
[TBL] [Abstract][Full Text] [Related]
30. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality.
Hahm C; Mun YC; Seong CM; Chung WS; Huh J
Ann Lab Med; 2012 Nov; 32(6):445-9. PubMed ID: 23130347
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literature.
Akhila Raj TV; Gopinath P; Geetha Raj JA; Narayanan G; Nair SG; Joy Philip DS; Raveendran S; Geetha P; Sreedharan H
J Cancer Res Ther; 2022; 18(3):697-703. PubMed ID: 35900542
[TBL] [Abstract][Full Text] [Related]
32. A case of acute myeloid leukemia (AML) with an unreported combination of chromosomal abnormalities: gain of isochromosome 5p, tetrasomy 8 and unbalanced translocation der(19)t(17;19)(q23;p13).
Paar C; Herber G; Voskova D; Fridrik M; Stekel H; Berg J
Mol Cytogenet; 2013 Sep; 6(1):40. PubMed ID: 24079663
[TBL] [Abstract][Full Text] [Related]
33. Recurrent cytogenetic abnormalities observed in complete remission of acute myeloid leukemia do not necessarily mark preleukemic cells.
Raynaud SD; Brunet B; Chischportich M; Bayle J; Gratecos N; Pesce A; Dujardin P; Flandrin G; Ayraud N
Leukemia; 1994 Feb; 8(2):245-9. PubMed ID: 8309249
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.
Panagopoulos I; Torkildsen S; Gorunova L; Ulvmoen A; Tierens A; Zeller B; Heim S
Oncol Rep; 2016 Nov; 36(5):2481-2488. PubMed ID: 27667292
[TBL] [Abstract][Full Text] [Related]
35. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
36. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients.
Alpermann T; Haferlach C; Eder C; Nadarajah N; Meggendorfer M; Kern W; Haferlach T; Schnittger S
Leuk Res; 2015 Mar; 39(3):265-72. PubMed ID: 25592059
[TBL] [Abstract][Full Text] [Related]
37. RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall.
Menter T; Lundberg P; Wenzel F; Dirks J; Fernandez P; Friess D; Dirnhofer S; Tzankov A
Pathobiology; 2019; 86(2-3):162-166. PubMed ID: 30396184
[TBL] [Abstract][Full Text] [Related]
38. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
39. Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality.
Torkildsen S; Gorunova L; Heim S; Tjønnfjord GE; Spetalen S; Risberg B; Tran HTT; Panagopoulos I
Cancer Genomics Proteomics; 2019; 16(3):175-178. PubMed ID: 31018948
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
